» Articles » PMID: 10411627

The Structural Basis for the Regulation of Tissue Transglutaminase by Calcium Ions

Overview
Journal Eur J Biochem
Specialty Biochemistry
Date 1999 Jul 20
PMID 10411627
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

The role of calcium ions in the regulation of tissue transglutaminase is investigated by experimental approaches and computer modeling. A three-dimensional model of the transglutaminase is computed by homology building on crystallized human factor XIII and is used to interpret structural and functional results. The molecule is a prolate ellipsoid (6.2 x 4.2 x 11 nm) and comprises four domains, assembled pairwise into N-terminal and C-terminal regions. The active site is hidden in a cleft between these regions and is inaccessible to macromolecular substrates in the calcium-free form. Protein dynamics simulation indicates that these regions move apart upon addition of calcium ions, revealing the active site for catalysis. The protein dimensions are consistent with results obtained with small-angle neutron and X-ray scattering. The gyration radius of the protein (3 nm) increases in the presence of calcium ions (3.9 nm), but it is virtually unaffected in the presence of GTP, suggesting that only calcium ions can promote major structural changes in the native protein. Proteolysis of an exposed loop connecting the N-terminal and C-terminal regions is linearly correlated with enzyme inactivation and prevents the calcium-induced conformational changes.

Citing Articles

Pathogenetic Contributions and Therapeutic Implications of Transglutaminase 2 in Neurodegenerative Diseases.

Liu J, Mouradian M Int J Mol Sci. 2024; 25(4).

PMID: 38397040 PMC: 10888553. DOI: 10.3390/ijms25042364.


A Calcium- and GTP-Dependent Transglutaminase in .

Almugadam S, Trentini A, Maritati M, Contini C, Manfrinato M, Cervellati C Vet Sci. 2023; 10(3).

PMID: 36977273 PMC: 10053793. DOI: 10.3390/vetsci10030234.


The Impact of -Acryloyllysine Piperazides on the Conformational Dynamics of Transglutaminase 2.

Heerwig A, Kick A, Sommerfeld P, Eimermacher S, Hartung F, Laube M Int J Mol Sci. 2023; 24(2).

PMID: 36675164 PMC: 9865645. DOI: 10.3390/ijms24021650.


Exploring the Role of Transglutaminase in Patients with Glioblastoma: Current Perspectives.

Katt W, Aplin C, Cerione R Onco Targets Ther. 2022; 15:277-290.

PMID: 35340676 PMC: 8943831. DOI: 10.2147/OTT.S329262.


Heterologous Expression of Recombinant Transglutaminase in SCK6 with Optimized Signal Peptide and Codon, and Its Impact on Gelatin Properties.

Wang S, Yang Z, Li Z, Tian Y J Microbiol Biotechnol. 2020; 30(7):1082-1091.

PMID: 32325545 PMC: 9728238. DOI: 10.4014/jmb.2002.02049.